1. Home
  2. ZLAB vs IGT Comparison

ZLAB vs IGT Comparison

Compare ZLAB & IGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • IGT
  • Stock Information
  • Founded
  • ZLAB 2013
  • IGT 2014
  • Country
  • ZLAB China
  • IGT United Kingdom
  • Employees
  • ZLAB N/A
  • IGT N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • IGT Services-Misc. Amusement & Recreation
  • Sector
  • ZLAB Health Care
  • IGT Consumer Discretionary
  • Exchange
  • ZLAB Nasdaq
  • IGT Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • IGT 3.2B
  • IPO Year
  • ZLAB 2017
  • IGT N/A
  • Fundamental
  • Price
  • ZLAB $29.76
  • IGT $14.40
  • Analyst Decision
  • ZLAB Buy
  • IGT Strong Buy
  • Analyst Count
  • ZLAB 4
  • IGT 4
  • Target Price
  • ZLAB $47.37
  • IGT $23.25
  • AVG Volume (30 Days)
  • ZLAB 944.8K
  • IGT 2.4M
  • Earning Date
  • ZLAB 05-08-2025
  • IGT 05-13-2025
  • Dividend Yield
  • ZLAB N/A
  • IGT 5.44%
  • EPS Growth
  • ZLAB N/A
  • IGT 44.55
  • EPS
  • ZLAB N/A
  • IGT 1.62
  • Revenue
  • ZLAB $418,326,000.00
  • IGT $2,434,000,000.00
  • Revenue This Year
  • ZLAB $44.07
  • IGT $2.39
  • Revenue Next Year
  • ZLAB $49.13
  • IGT $1.52
  • P/E Ratio
  • ZLAB N/A
  • IGT $8.99
  • Revenue Growth
  • ZLAB 43.72
  • IGT 14.38
  • 52 Week Low
  • ZLAB $16.01
  • IGT $13.81
  • 52 Week High
  • ZLAB $39.77
  • IGT $24.13
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 44.77
  • IGT 34.39
  • Support Level
  • ZLAB $30.11
  • IGT $14.90
  • Resistance Level
  • ZLAB $31.34
  • IGT $15.79
  • Average True Range (ATR)
  • ZLAB 1.06
  • IGT 0.59
  • MACD
  • ZLAB -0.02
  • IGT -0.19
  • Stochastic Oscillator
  • ZLAB 36.04
  • IGT 0.17

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About IGT International Game Technology

International Game Technology PLC is a gaming company that delivers entertaining and responsible gaming experiences for players across all channels. The company operates into single segment namely Gaming & Digital. Geographically, it derives a majority of revenue from the United States. The company also has its presence in Italy, Rest of Europe and Other countries.

Share on Social Networks: